ROS可以加速过度缩性心肌病变的进展
Jinhua Cao1,2, Yafei Zhai1,2, Ke Li1,2
1Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
Genes & diseases
|October 29, 2025
概括
在MYBPC3中发生的突变会导致过度缩性心肌病变. 这项研究使用了MYBPC3淘汰赛模型,以表明减少活性氧物种 (ROS) 可以改善心脏功能和细胞损伤在这种情况下.
科学领域:
- 心脏病学 心脏病学
- 干细胞生物学 干细胞生物学
- 分子生物学分子生物学
背景情况:
- MYBPC3突变是导致心肌缩性心脏病 (HCM) 的首要遗传原因.
- 了解HCM的发病因子对于开发有效的治疗方法至关重要.
研究的目的:
- 研究MYBPC3在心脏功能和病理学的作用.
- 使用人类诱导的多能干细胞干细胞衍生的心肌细胞 (hiPSC-CM) 模型,探索MYBPC3相关的HCM的潜在治疗策略.
主要方法:
- 一个MYBPC3淘汰赛 (KO) hiPSC-CM模型的生成.
- 评估心脏收缩性,处理,活性氧物种 (ROS) 水平和线粒体功能.
- RNA测序以确定异常路径.
- 用黑素治疗MYBPC3删除的hiPSC-CMs.
主要成果:
- 删除MYBPC3的hiPSC-CMs表现出心力衰竭的特征,包括心脏收缩能力的改变,异常的处理,ROS的增加和线粒体损伤.
- RNA测序揭示了异常的氧化应激路径和与HCM相关的变化.
- 黑色素治疗恢复了处理,降低了ROS水平,并改善了MYBPC3删除的hiPSC-CMs中的收缩性.
结论:
- 缺少MYBPC3会导致细胞特征的多变性心肌病.
- 氧化应激在HCM的发病过程中起着重要作用.
- 降低ROS水平,例如,通过黑激素,可以改善这个模型中的HCM表型.
更多相关视频
10:21Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
10.6K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.9K
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
393
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
393
01:30Cardiomyopathy II: Dilated Cardiomyopathy
457
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
457
01:29Cardiomyopathy V: Interprofessional Care
331
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
331
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
444
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
444
01:29Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
01:25Cardiomyopathy I: Introduction and Classification
492
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
492